Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 4
2005 8
2006 12
2007 12
2008 6
2009 9
2010 11
2011 3
2012 6
2013 9
2014 6
2015 15
2016 16
2017 13
2018 14
2019 10
2020 13
2021 8
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Gillison ML, et al. Among authors: harari pm. Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449625 Free PMC article. Clinical Trial.
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: harari pm. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: harari pm. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
The Model of an ASTRO Servant Leader.
DeWeese TL, Beyer D, Gunderson LL, Haffty BG, Harari PM, Lawton CA, Minsky BD, Steinberg ML. DeWeese TL, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1120-1121. doi: 10.1016/j.ijrobp.2021.08.014. Int J Radiat Oncol Biol Phys. 2021. PMID: 34793736 No abstract available.
Life Beyond COVID: Pay Attention to Viruses.
Harari PM, Lambert PF. Harari PM, et al. Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):348-350. doi: 10.1016/j.ijrobp.2020.07.001. Int J Radiat Oncol Biol Phys. 2020. PMID: 32890509 Free PMC article. No abstract available.
The Promise of Combining Radiation Therapy With Immunotherapy.
Jagodinsky JC, Harari PM, Morris ZS. Jagodinsky JC, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):6-16. doi: 10.1016/j.ijrobp.2020.04.023. Epub 2020 Apr 23. Int J Radiat Oncol Biol Phys. 2020. PMID: 32335187 Free PMC article. Review.
Cetuximab (Imclone/Merck/Bristol-Myers Squibb).
Kies MS, Harari PM. Kies MS, et al. Among authors: harari pm. Curr Opin Investig Drugs. 2002 Jul;3(7):1092-100. Curr Opin Investig Drugs. 2002. PMID: 12186273 Review.
Emphasize Treatment of Known Disease Rather Than Past Footprints.
Witek ME, Harari PM. Witek ME, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):904. doi: 10.1016/j.ijrobp.2019.09.023. Int J Radiat Oncol Biol Phys. 2020. PMID: 32171461 No abstract available.
166 results